Seeded with $1 million from Silicon Valley tech entrepreneur and philanthropist Steve Kirsch, the fund is targeting early-stage infections in outpatients — as opposed to hospitalized, critically ill patients — as a way to prevent disease progression to the severe and often fatal stage….

Goto full post >>